What Is Alzheimer's Disease? Stages, Symptoms, and What to Know

Why Understanding Alzheimer's Matters

Alzheimer's disease affects more than 7 million Americans and is the seventh-leading cause of death in the United States. Beyond the individual diagnosed, the ripple effects extend to families, caregivers, and communities. Understanding what the disease actually involves, rather than relying on assumptions, helps families recognize early signs, seek timely evaluation, and make informed decisions about care and planning.

Many people conflate Alzheimer's with dementia, but dementia is an umbrella term that encompasses several conditions. Alzheimer's is one specific cause of dementia, distinguished by its underlying biology and characteristic progression pattern. For a comparison of the major dementia types, see our guide on types of dementia explained. For a broader overview of cognitive diagnoses, see our guide on cognitive conditions explained.

Key Facts at a Glance

• Alzheimer's accounts for 60 to 80 percent of all dementia cases.
• More than 7 million Americans are currently living with the disease.
• The greatest known risk factor is advancing age, with most diagnoses occurring after age 65.
• Alzheimer's progresses through recognizable stages, from mild memory changes to severe impairment.
• The disease is caused by abnormal protein deposits, amyloid plaques and tau tangles, that accumulate in the brain.
• Some risk factors, including cardiovascular health, physical activity, and social engagement, are modifiable.
• Early detection creates a window for treatment, planning, and access to clinical trials.

What Causes Alzheimer's Disease

Alzheimer's develops when two abnormal proteins accumulate in the brain. Amyloid plaques form between neurons from fragments of a larger protein called amyloid precursor protein. Tau tangles develop inside neurons when the tau protein, which normally supports cell structure, becomes misshapen and clumps together. According to the National Institute on Aging, these changes begin years or even decades before symptoms appear, gradually disrupting communication between brain cells and eventually causing cell death.

The brain regions affected first are typically those involved in forming new memories, which is why memory loss is usually the earliest symptom. As the disease progresses, damage spreads to areas controlling language, reasoning, spatial awareness, and behavior.

Researchers do not yet fully understand why some people develop these protein accumulations and others do not. The answer likely involves a combination of genetic predisposition, age-related changes, and environmental and lifestyle factors that interact over a lifetime.

Risk Factors

The National Institute on Aging identifies several factors that influence Alzheimer's risk.

Age is the strongest known risk factor. The likelihood of developing Alzheimer's roughly doubles every five years after age 65. However, the disease is not an inevitable part of aging.

Family history and genetics play a meaningful role. Having a first-degree relative with Alzheimer's increases risk, and certain gene variants, most notably APOE-e4, are associated with higher susceptibility. Rare genetic mutations can cause early-onset Alzheimer's, which appears before age 65.

Cardiovascular health has a significant connection to brain health. Conditions including high blood pressure, high cholesterol, type 2 diabetes, and obesity in midlife are all associated with increased Alzheimer's risk. The Mayo Clinic notes that what is good for the heart tends to be good for the brain.

Other factors that may influence risk include head injuries, limited social engagement, lower levels of education and cognitive stimulation, chronic sleep disturbances, and smoking.

Stages of Alzheimer's Disease

Alzheimer's progresses through broadly recognizable stages, though the timeline varies significantly between individuals.

Preclinical stage. Brain changes have begun, but there are no noticeable symptoms. This phase can last years or decades. Research tools like PET scans and cerebrospinal fluid analysis can detect amyloid buildup during this stage, but these are currently used primarily in research settings.

Mild cognitive impairment due to Alzheimer's. Memory and thinking difficulties become noticeable and measurable on cognitive tests, but daily independence is largely preserved. Not everyone with MCI progresses to Alzheimer's dementia. Understanding what mild cognitive impairment is can help families recognize this transitional phase and take proactive steps.

Mild Alzheimer's dementia. Cognitive changes begin to interfere with daily activities. Common signs include difficulty managing finances, trouble following recipes or plans that were once routine, getting lost in familiar places, repeating questions, and misplacing things in unusual locations. Personality changes such as withdrawal from social activities or increased anxiety may also appear.

Moderate Alzheimer's dementia. This is typically the longest stage. Confusion and memory loss deepen. Individuals may have difficulty recognizing family and friends, experience changes in sleep patterns, become suspicious or agitated, and need increasing help with daily tasks like dressing and bathing. Wandering and getting lost become safety concerns.

Severe Alzheimer's dementia. Individuals lose the ability to communicate coherently, require full-time assistance with all activities, and eventually lose awareness of their surroundings. Physical abilities decline, including the ability to walk, sit, and swallow.

How Alzheimer's Is Diagnosed

No single test can definitively diagnose Alzheimer's in a living person, but a thorough clinical evaluation can establish a diagnosis with high confidence. The process typically includes:

• Cognitive testing. Standardized assessments measure memory, attention, language, visuospatial abilities, and executive function, providing an objective picture of current cognitive status.
• Medical history and symptom timeline. Documenting when changes began, how they have progressed, and which cognitive domains are affected.
• Neurological and physical examination. Evaluating reflexes, coordination, balance, and sensory function for signs of other neurological conditions.
• Blood tests. Ruling out treatable causes of cognitive decline such as thyroid disorders, vitamin deficiencies, and infections. Newer blood-based biomarker tests can now detect amyloid and tau proteins with increasing reliability.
• Brain imaging. MRI scans can reveal patterns of brain atrophy consistent with Alzheimer's, while PET scans can detect amyloid plaques directly.

The earlier cognitive changes are evaluated, the more options are available. Early diagnosis enables access to emerging disease-modifying treatments, enrollment in clinical trials, and time to make legal, financial, and care plans while the person can still participate in those decisions.

Living with Alzheimer's

An Alzheimer's diagnosis is life-changing, but it is not the end of meaningful life. Many people live for years after diagnosis, particularly when the disease is identified early. Practical steps that support quality of life include:

• Establishing routines. Consistent daily schedules reduce confusion and provide a sense of security.
• Simplifying the environment. Reducing clutter, labeling drawers and cabinets, and removing tripping hazards help maintain independence longer.
• Staying physically and socially active. Regular exercise and social engagement are associated with slower cognitive decline according to the Alzheimer's Association.
• Planning ahead. Addressing legal, financial, and healthcare directives while the individual can still participate allows their preferences to guide future decisions.
• Building a care team. Connecting with healthcare providers, support groups, and community resources helps both the individual and their family manage the road ahead.

Taking the Next Step

For a broader look at how Alzheimer's compares to other cognitive conditions, read our guide on cognitive conditions explained.

If you want to establish a personal cognitive baseline and track changes over time, explore how Orena's FDA-cleared at-home test works.